Eledon Pharma Q4 EPS $(0.10) Beats $(0.18) Estimate

Eledon Pharma (NASDAQ: ELDN) reported a Q4 loss of $(0.10) per share, surpassing the analyst consensus estimate of $(0.18) by 45.95%. This represents an 84.38% improvement compared to losses of $(0.64) per share in the same quarter last year.